Ongoing, recruitingTherapeutic confirmatory (Phase III)Interventional

J1I-MC-GZBM: A Randomized, Double-Blind, Phase 3 Study to Investigate the Efficacy and Safety of LY3437943 Once Weekly Compared to Placebo in Participants with Severe Obesity and Established Cardiovascular Disease (TRIUMPH-3)

At a glance

Status

Ongoing, recruiting

Phase

Therapeutic confirmatory (Phase III)

Sponsor

Eli Lilly & Co.

Enrolment target

389

Start

22 Aug 2023

Percent Change from Baseline in Body Weight

Age 18 Years to any · Sex: All

Always speak to your GP or specialist before deciding to take part in a study.